On ECHEMI
Home > Drugs > Ranitidine Hydrochloride Capsules

Ranitidine Hydrochloride Capsules

Function and Efficacy

1. Pharmacology Ranitidine has the effect of competitively blocking the binding of histamine to H2 receptors. It inhibits gastric acid action, which is 5 to 12 times that of cimetidine in terms of moles. Therefore, it is a potent H2 receptor blocker. 2. Toxicity Oral LD50 of mice is 1440~1750mg/Kg. The maximum non-toxic dose per day for 5 consecutive weeks is 500mg/Kg for rats (male), 250mg/Kg for rats (female), and 40mg/Kg for dogs. The maximum non-toxic dose per day for 26 consecutive weeks is 100mg/Kg for rats and 40mg/Kg for dogs. Mice were orally administered 100~200mg/Kg for 114 weeks, and rats were orally administered 100~2000mg/Kg for 129 weeks, and no carcinogenic effect was observed.

Ingredients

Ranitidine hydrochloride, its chemical name is: N'-methyl-N-[2-[[[5-[(dimethylamino)methyl]-2-furyl]-methyl]thio]ethyl]-2-nitro-1,1-ethylenediamine hydrochloride.

Name Description Content CAS NO. Manufacturer
Ranitidine HydrochlorideIngredients

It competitively blocks the binding of histamine to H2 receptors, inhibits gastric acid secretion, and is a potent H2 receptor blocker.

More
66357-59-3 49

Appearance

This product is a capsule, and its contents are off-white or light yellow powder.

Indication

Used to treat duodenal ulcer, gastric ulcer, reflux esophagitis, Zollinger-Ellison syndrome and other high gastric acid secretion diseases.

Usage and Dosage

1. Oral, 150 mg (1 tablet at a time), twice a day, or 300 mg (2 tablets at a time), once before bedtime. 2. Maintenance treatment: Oral, 150 mg (1 tablet at a time), once every night. 3. For patients with severe renal disease, the half-life of ranitidine is prolonged, and the dose should be reduced to 75 mg (half a tablet at a time), twice a day. 4. For the treatment of Zollinger-Ellison syndrome, a large amount of 600~1200 mg per day (4~8 tablets per day) is recommended.

Adverse Reactions

1. Common symptoms include nausea, rash, constipation, fatigue, headache, dizziness, etc. 2. Compared with cimetidine, the adverse effects of damage to kidney function, gonadal function and central nervous system are milder. 3. A small number of patients suffered mild liver damage after taking the drug, and the symptoms disappeared after stopping the drug, and the liver function returned to normal. It was suspected that it might be a drug allergic reaction and had nothing to do with the dosage of the drug. 4. Long-term use can continuously reduce the acidity of gastric juice, which is conducive to the reproduction of bacteria in the stomach, thereby reducing nitrates in food to nitrites and forming N-nitroso compounds.

Precautions

It is not suitable for children under 8 years old. It is not suitable for pregnant or lactating women.

Special Population Medication

Precautions for children: Children under 8 years old are prohibited. Precautions for pregnancy and lactation: Precautions for pregnant and lactating women. Precautions for the elderly: The liver and kidney functions of the elderly are reduced. To ensure the safety of medication, the dosage should be adjusted.

Drug Interactions

1. When used with warfarin, lidocaine, diazepam, propranolol and other drugs that are metabolized by the liver, the blood concentration of ranitidine will not increase and cause toxic side effects. 2. When used with anticoagulants and anti-epileptic drugs, it is safer than cimetidine. 3. When used with procainamide, the clearance rate of procainamide can be reduced. 4. It can reduce liver blood flow, so when used with propranolol, lidocaine and other drugs whose metabolism is greatly affected by liver blood flow, it can delay the effects of these drugs.

Storage

Keep in a dark place, sealed and stored in a dry place

Packaging Specification

0.15g (based on ranitidine)

Validity Period

24 months

Manufacturer

Harbin Guokang Pharmaceutical Co., Ltd.

  • Founded in:

    2002-09-06
  • Address:

    Nanjing Road, Limin Development Zone, Harbin
  • Tax NO.:

    91230111727698227H
  • Registered Funds:

    33 million yuan
  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.